2027 Summer Internship Program: Statistics Summer Intern in Clinical Data Science
Takeda
Summary
At Takeda, the Clinical Data Science (CDS) organization partners across Research and Development (R&D) to apply statistical thinking, quantitative methods, and data science to support evidence generation and informed decision-making. The team works collaboratively with clinicians, scientists, programmers, and other cross-functional partners to address important drug development questions and advance innovative analytical approaches.
Job description
We are seeking a highly motivated and talented PhD candidate to join our Clinical Data Science team for the 2027 Summer Internship Program. This internship offers an opportunity to gain hands-on experience in the pharmaceutical industry while contributing to innovative statistical research relevant to clinical drug development. The summer intern will work closely with experienced statisticians on an innovative research project focused on developing and evaluating a practical Bayesian predictive framework to support oncology Go/No-Go decisions.
How You Will Contribute
- Conduct focused literature reviews on Bayesian predictive probability methods and oncology Go/No-Go frameworks.
- Develop, implement, and evaluate Bayesian predictive probability methods to address research questions relevant to clinical trials and oncology drug development.
- Design and conduct simulation studies to assess methodological performance under various scenarios and assumptions.
- Develop reproducible analytical workflows using R and/or Python.
- Collaborate with statisticians and interpret research findings to explore their potential applications.
- Present key findings and deliver a final presentation to the broader team at the conclusion of the internship.
- Prepare a scientific manuscript summarizing the research methodology and findings for potential publication in a peer-reviewed statistical journal.
Internship Development Opportunities
- Gain practical experience applying Bayesian predictive modeling to real-world challenges in pharmaceutical research and development.
- Develop a deeper understanding of clinical trial design, oncology drug development, and the role of quantitative sciences in clinical decision-making.
- Receive mentorship and technical guidance from experienced statisticians and data scientists.
- Strengthen research, programming, problem-solving, and scientific communication skills.
- Collaborate with multidisciplinary teams and gain exposure to the pharmaceutical drug development process.
- Explore opportunities to contribute to scientific publications or conference presentations.
Job Requirements
Education: Currently enrolled in a PhD program in Statistics, Biostatistics, or a closely related quantitative discipline. Preferably completed at least two years of doctoral-level coursework or research.
Required Skills: Strong foundation in statistical theory and advanced knowledge in Bayesian statistics and survival analysis. Familiarity with oncology clinical trial endpoints, including overall survival (OS), progression-free survival (PFS), and objective response rate (ORR). Strong programming proficiency in R and/or Python, with experience conducting simulation studies.
Preferred Qualifications: Strong written and verbal communication. Familiarity with oncology drug development, clinical trial design, or pharmaceutical research. Experience conducting independent methodological research or developing reproducible analytical workflows.
Work Location: Onsite (Cambridge, MA) / Hybrid / Remote
Internship Eligibility
- Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
- Must be currently enrolled in a degree program graduating December 2027 or later
- The internship program is 10-12 weeks depending on the two start dates (June 1st - August 20th OR June 14th - August 20th)
- The intern must be able to commit to one of these time frames
- Able to work full time 40 hours a week during internship dates
- Takeda does not provide a housing stipend or relocation support for the U.S Summer Internship Program
Requirements
- Currently enrolled in a PhD program in Statistics, Biostatistics, or a closely related quantitative discipline
- Strong foundation in statistical theory
- Advanced knowledge in Bayesian statistics and survival analysis
- Familiarity with oncology clinical trial endpoints (OS, PFS, ORR)
- Strong programming proficiency in R and/or Python
- Experience conducting simulation studies
- Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
- Must be currently enrolled in a degree program graduating December 2027 or later
- Able to work full time 40 hours a week during internship dates
- Commit to one of the internship time frames (June 1 - August 20 OR June 14 - August 20)
Benefits
- Paid Sick Time
- Civic Duty PTO
- Company Volunteer Events
- Company Sponsored Events
- On-site Fitness Center
- Commuter Benefit
Company overview
Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company founded in 1781 and incorporated in 1925. As one of the world's top 20 largest pharmaceutical companies by revenue and the third largest in Asia, Takeda specializes in developing and commercializing innovative medicines across several therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. With approximately 49,095 employees globally, the company operates research and development centers, manufacturing facilities, and commercial operations across 39 U.S. states and numerous countries worldwide. Takeda maintains dual headquarters in Tokyo and Osaka, Japan, with significant operations in Cambridge, Massachusetts, where it serves as the largest life sciences employer in the state. The company's patient-focused approach is guided by its Takeda-ism values of Integrity, Fairness, Honesty, and Perseverance, emphasizing a commitment to delivering life-transforming treatments while advancing sustainable healthcare solutions. Takeda's extensive portfolio includes both innovative biologics and small molecule drugs, supported by strategic acquisitions and partnerships that have expanded its capabilities in areas such as immuno-oncology and rare disease treatments.